Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.

Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.

Item
http://www.wikidata.org/entity/Q40896731
Mutational analysis of the v-Rel dimerization interface reveals a critical role for v-Rel homodimers in transformationDeletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein RELNF-kappaB2 mutation targets TRAF1 to induce lymphomagenesis.Constitutive production of NF-kappaB2 p52 is not tumorigenic but predisposes mice to inflammatory autoimmune disease by repressing Bim expression.NFκB function and regulation in cutaneous T-cell lymphoma.Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-kappaB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes.Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells.
P2860

Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.

Item
http://www.wikidata.org/entity/Q40896731
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Mutant envelope residues confe ...... nces of the v-Rel oncoprotein.
@en
type
label
Mutant envelope residues confe ...... nces of the v-Rel oncoprotein.
@en
prefLabel
Mutant envelope residues confe ...... nces of the v-Rel oncoprotein.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P6179
P698
P356
P1433
P1476
Mutant envelope residues confe ...... nces of the v-Rel oncoprotein.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P6179
P698